by TractManager | Sep 1, 2021 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing molecular testing for monoclonal T-cell receptor (TCR) gene rearrangements to aid diagnosis and/or staging of mature/peripheral T-cell lymphoma.If you have a Hayes login, click...
by TractManager | Sep 1, 2021 | News
The Food and Drug Administration (FDA) is requiring new and updated warnings for Janus kinase (JAK) inhibitors Xeljanz/Xeljanz XR (tofacitinib; Pfizer), Olumiant (baricitinib; Eli Lilly and Co.), and Rinvoq (upadacitinib; AbbVie Inc).The FDA completed a review of a...
by TractManager | Aug 31, 2021 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of intravascular lithotripsy (IVL) for treatment of calcified arteries in patients with coronary artery disease...
by TractManager | Aug 31, 2021 | Emerging Technology Report
The Vivistim Paired VNS System is an implanted neurostimulator system intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with...
by TractManager | Aug 17, 2021 | Emerging Technology Report
Oportuzumab monatox is an antibody-drug conjugate that targets epithelial cell-adhesion molecule (EpCAM) in development for the treatment of bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer. It is an intravesical treatment, administered through...
Recent Comments